She is committed to providing excellent patient care and translating research to patients.
- juvenile idiopathic arthritis (JIA)
- JIA and non-JIA associated uveitis
- inflammatory and non-inflammatory bone diseases
- adnexal inflammation
Qualifications and training
1993 MD (France)
1999 MSc (France)
2001 Paediatrics (France)
2005 Paediatric Rheumatology (Canada)
Dr Lacassagne is a co-investigator, along with Mr Edelsten, in the Sycamore study (phase III RCT, adalimumab versus placebo in JIA-associated uveitis).
She has an interest in quality improvement, in particular in the treat to target approach.
She is passionate about bringing research back to patients by using biomarkers and personalised medicine.